Skip to main content
SpringerLink
Log in

Wirkprofile klassischer Neuroleptika und die Beeinflussung von Minussymptomatik

  • Chapter
Neuere Ansätze zur Diagnostik und Therapie schizophrener Minussymptomatik

Zusammenfassung

Aus klinischer Sicht werden positive Symptome im Sinne einer produktiven Neubildung definiert, negative Symptome im Sinne des Verlustes sog. normaler oder gesunder Funktionen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • AMDP/Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie (Hrsg) (1981) Das AMDP-System. Manual zur Dokumentation psychiatrischer Befunde, 4. Aufl. Springer, Berlin Heidelberg New York.

    Google Scholar 

  • Andreasen NC (1983) The Scale for the Assessment of Negative Symptoms (SANS). University of Iowa, Iowa City.

    Google Scholar 

  • Angst J, Woggon B (1983) Validity of the AMDP-System for its use in clinical psychopharmacology. In: Bobon D, Baumann U, Angst J, Helmchen H, Hippius H (eds) The AMDP-System in Pharmacopsychiatry. Karger, Basel.

    Google Scholar 

  • Angst J, Stassen HH, Woggon B (1989) Effect of neuroleptics on positive and negative symptoms and the deficit state. Psychopharmacology 99: 41–46.

    Article  Google Scholar 

  • Ban TA, Guy W, Wilson WH (1985) The AMDP-system in chronic hospitalized schizophrenics. Compr Psychiatry 26: 370–374.

    Article  PubMed  CAS  Google Scholar 

  • Barnes TR, Braude WM (1985) Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry 42: 874–878.

    Article  PubMed  CAS  Google Scholar 

  • Bleuler M (1972) Die schizophrenen Geistesstörungen im Lichte langjähriger Kranken-und Familiengeschichten. Thieme, Stuttgart.

    Google Scholar 

  • Ciompi L, Müller C (1976) Lebensweg und Alter der Schizophrenen. Eine katamnestische Langzeitstudie bis ins Senium. Springer, Berlin Heidelberg New York.

    Google Scholar 

  • Conrad K (1958) Die beginnende Schizophrenie. Versuch einer Gestaltanalyse des Wahns. Thieme, Stuttgart.

    Google Scholar 

  • Crow TJ (1980) Molecular pathology of schizophrenia: more than one dimension of pathology? Br Med J 280: 66–68.

    Article  PubMed  CAS  Google Scholar 

  • Csernansky JG, Kaplan J, Hollister LE (1985) Problems in classification of schizophrenics as neuroleptic responders and nonresponders. J Nerv Ment Dis 173: 325–331.

    Article  PubMed  CAS  Google Scholar 

  • Csernansky JG, Kaplan J, Holman CA, Hollister LE (1983) Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients. Psychopharmacology 81: 115–118.

    Article  PubMed  CAS  Google Scholar 

  • Ernst K (1962) Neurotische und endogene Residualzustände. Arch Psychiatr Neurol 203: 61–84.

    Article  CAS  Google Scholar 

  • Goffmann E (1961) Asylums. Anchor Books, New York.

    Google Scholar 

  • Goldberg SC (1985) Negative and deficit symptoms in schizophrenia do respond to neuroleptics. Schizophr Bull 11: 453–456.

    PubMed  CAS  Google Scholar 

  • Goldberg SC, Klerman GL, Cole JO (1965) Changes in schizophrenic psychopathology and ward behavior as function of phenothiazine treatment. Br J Psychiatry 11: 120–133.

    Article  Google Scholar 

  • Good I (1989) Minussymptomatik bei chronischer Schizophrenie (Interraterreliabilität zweier Minussymptomatik-Skalen (SANS und NSRS). Med. Dissertation, Psych. Universitätsklinik Zürich.

    Google Scholar 

  • Heinrich K (1967) Zur Bedeutung des postremissiven Erschöpfungs-Syndroms für die Rehabilitation Schizophrener. Nervenarzt 38: 487–491.

    PubMed  CAS  Google Scholar 

  • Herrera JM, Sramek JJ, Costa JF (1987) Efficacy of adjunctive carbamazepine in the treatment of chronic schizophrenia. Drug Intell Clin Pharm 21: 355–358.

    PubMed  CAS  Google Scholar 

  • Hirsch SR, Knights A (1982) Gibt es die pharmakogene Drepression wirklich? Beweismaterial aus zwei prospektiven Untersuchungen. In: Kryspin-Exner K, Hinterhuber H, Schubert H (Hrsg) Ergebnisse der psychiatrischen Therapieforschung. Schattauer, Stuttgart, S 249–268.

    Google Scholar 

  • Hoffmann WF, Labs SM, Casey DE (1987) Neuroleptic-induced Parkinsonism in older schizophrenics. Biol Psychiatry 22: 427–439.

    Article  Google Scholar 

  • Huber G (1987) 13 Langzeituntersuchungen bei Schizophrenien. In: Kaschka WP, Joraschky P, Lungershausen E (Hrsg) Die Schizophrenien. Tropon-Symposium III. Springer, Berlin Heidelberg New York Tokyo.

    Google Scholar 

  • Huber G, Gross G, Schüttler R (1979) Schizophrenie. Verlaufs-und sozialpsychiatrische Langzeituntersuchungen an den 1945-1959 in Bonn hospitalisierten schizophrenen Kranken. Springer, Berlin Heidelberg New York.

    Google Scholar 

  • Iager AC, Kirch DG, Wyatt RJ (1985) A negative symptom rating scale. Psychiatry Res 16: 27–36.

    Article  PubMed  CAS  Google Scholar 

  • Kane JM, Mayerhoff D (1989) Do negative symptoms respond to pharmacological treatment. Br J Psychiatry 155 (Suppl 7): 115–118.

    Google Scholar 

  • Kane JM, Honigfeld G, Singer J, Meltzer H, and the Clozaril Collaborative Study Group (1989) Clozapine for the treatment-resistant schizophrenic: results of a US multicenter trial. Psychopharmacology 99: 60–63.

    Article  Google Scholar 

  • Mayer-Gross W (1920) Über die Stellungnahme zur abgelaufenen akuten Psychose. Eine Studie über verständliche Zusammenhänge in der Schizophrenie. Z Ges Neurol Psychiatr 60: 160–212.

    Article  Google Scholar 

  • Meltzer HY (1986) Effect of neuroleptics on the schizophrenia syndrome. In: Dahl SG, Gram LF, Paul SM, Potter WZ (eds) Clinical pharmacology in psychiatry. Selectivity in psycho tropic drug action — promises or problems. Springer, Berlin Heidelberg New York Tokyo, pp 255–265.

    Google Scholar 

  • Meltzer HY, Zureick J (1989) Negative symptoms in schizophrenia: A target for new drug development. In: Dahl SG, Gram LF (eds) Clinical pharmacology in psychiatry. Psychopharmacology Series, vol 7. Springer, Berlin Heidelberg New York Tokyo.

    Google Scholar 

  • Meltzer HY, Sommers AA, Luchins DJ (1986) The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia. J Clin Psychopharmacol 6: 329–338.

    Article  PubMed  CAS  Google Scholar 

  • Möller HJ, Zerssen D von (1981) Depressive Symptomatik bei Aufnahme und Entlassung stationär behandelter schizophrener Patienten. Nervenarzt 52: 525–530.

    PubMed  Google Scholar 

  • Möller HJ, Zerssen D von (1986) Der Verlauf schizophrener Psychosen unter den gegenwärtigen Behandlungsbedingungen. Springer, Berlin Heidelberg New York Tokyo.

    Book  Google Scholar 

  • Prosser ES, Csernansky JG, Kaplan J, Thiemann S, Becker TJ, Hollister LE (1987) Depression, Parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics. J Nerv Ment Dis 175: 100–105.

    Article  PubMed  CAS  Google Scholar 

  • Straumann D (1989) Sogenannte Minussymptome bei chronischer Schizophrenie. Med. Dissertation, Psych. Universitätsklinik Zürich.

    Google Scholar 

  • Waddington JL, Youssef HA (1986) Late onset involuntary movements in chronic schizophrenia: relationship of “tardive” dyskinesia to intellectual impairment and negative symptoms. Br J Psychiatry 149: 616–620.

    Article  PubMed  CAS  Google Scholar 

  • Waddington JL, Yousseff HA, Dolphin C, Kinsella A (1987) Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality. Arch Gen Psychiatry 44: 907–912.

    Article  PubMed  CAS  Google Scholar 

  • Waddington JL, Youssef HA, Molloy AG, O’Boyle KM, Pugh MT (1985) Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies. J Clin Psychiatry 46: 29–33.

    PubMed  CAS  Google Scholar 

  • Wing JK (1989) The concept of negative symptoms. Br J Psychiatry 155 (Suppl 7): 10–14.

    Google Scholar 

  • Woggon B, Angst J (1976) Einzelne Aspekte der Behandlung mit Depotneuroleptika. In: Huber G (Hrsg) Therapie, Rehabilitation und Prävention schizophrener Erkrankungen. 3. Weissenauer Schizophreniesymposion, Lübeck-Travemünde. Schattauer, Stuttgart, S 191–200.

    Google Scholar 

  • Woggon B, Beckmann H, Heinrich K et al. (1986) Clinically relevant differences in the therapeutic profile of fluperlapine compared to haloperidol in the treatment of schizophrenic psychosis. Results of amulticentre double-blind study. Pharmacopsychiatria 19: 204–205.

    Article  Google Scholar 

Download references

Authors
  1. B. Woggon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitäts-Nervenklinik und Poliklinik Psychiatrie, Sigmund-Freud-Str. 25, 5300, Bonn 1, Deutschland

    Hans-Jürgen Möller (Direktor) & Eva Pelzer (Direktor) & 

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Woggon, B. (1990). Wirkprofile klassischer Neuroleptika und die Beeinflussung von Minussymptomatik. In: Möller, HJ., Pelzer, E. (eds) Neuere Ansätze zur Diagnostik und Therapie schizophrener Minussymptomatik. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76263-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76263-5_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76264-2

  • Online ISBN: 978-3-642-76263-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation